| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/25/2006 | US20060111360 Bicyclic compounds as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 05/25/2006 | US20060111359 enzyme inhibitor for treating sleep disorders |
| 05/25/2006 | US20060111358 Treatment of aml |
| 05/25/2006 | US20060111357 Quinoline compounds for use in mch receptor related disorders |
| 05/25/2006 | US20060111356 External preparation for allergic diseases |
| 05/25/2006 | US20060111355 6-({(2S)-4-[2-(4-tert-butylphenyl)-1H-benzimidazol-4-yl]-2-methylpiperazin-1-yl}methyl)quinoxaline; orally bioavailable; prostate cancer, endometriosis, uterine fibroids, uterine cancer, breast cancer, ovarian cancer, testicular cancer, primary hirsutism, or LH surge |
| 05/25/2006 | US20060111354 Medicaments containing vardenafil hydrochloride trihydrate |
| 05/25/2006 | US20060111353 2-Cyclohexyl-1-(4-methanesulfonyl-phenyl)-cyclopropanecarboxylic acid 5-chloro-thiazol-2-yl)-amide; antidiabetic agents; non-insulin dependent diabetes; disorders associated with GK dysfunction; an enhanced solubility profile; improved metabolic stability; increased insulin secretion |
| 05/25/2006 | US20060111352 Acetylenic compounds useful in treating inflammatory disorders |
| 05/25/2006 | US20060111351 Aryl sulfonamides |
| 05/25/2006 | US20060111350 Solid forms of linezolid and processes for preparation thereof |
| 05/25/2006 | US20060111349 such as 3-[(Quinolin-4-ylmethyl)amino]-N-[4-methyl-3-(2-(4-(2-propyl)piperazin-1-yl)-3,4-dioxocyclobut-1-en-1-yl)phenyl]thiophene-2-carboxamide, having stem cell factor receptor inhibitory activity, used antitumor or anticarcinogenic agents |
| 05/25/2006 | US20060111348 synergistic mixture of [1-(4-Methoxy-phenyl)-5-methyl-1H-pyrazol-4-yl]-(1,3,3-trimethyl-6-aza-bicyclo[3.2.1]oct-6-yl)-methanone and hypotensive agent; insulin resistance, dyslipidemia, obesity |
| 05/25/2006 | US20060111347 Substituted sulfones and methods of use |
| 05/25/2006 | US20060111346 Methods of modulating high-density lipoprotein cholesterol levels and pharmaceutical formulations for the same |
| 05/25/2006 | US20060111345 Pharmaceutical compositions comprising a selective COX-2 inhibitor and a diuretic |
| 05/25/2006 | US20060111344 Arylethanolamine beta2-adrenoreceptor agonist compounds |
| 05/25/2006 | US20060111343 Oxcarbazepine dosage forms |
| 05/25/2006 | US20060111341 Use of galanthamine and the derivatives thereof in the production of medicaments |
| 05/25/2006 | US20060111340 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 05/25/2006 | US20060111339 Novel oral general anesthetics and metabolitically resistant anticonvulsants |
| 05/25/2006 | US20060111338 2-Amino-4-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
| 05/25/2006 | US20060111337 Substituted biaryl quinolin-4-ylamine analogues |
| 05/25/2006 | US20060111336 Improved DP-IV inhibitors increase the steady state concentrations of GLP-1 and GIP, resulting in improved glucose tolerance |
| 05/25/2006 | US20060111335 Photoactivated anti-viral and anti-cancer agent |
| 05/25/2006 | US20060111334 Oral solid dosage forms containing a low dose of estradiol |
| 05/25/2006 | US20060111333 Structural, behavioral characterization, and synthesis of attractants for migratory lamprey |
| 05/25/2006 | US20060111332 Process and intermediates to prepare17beta-hydroxy-7alpha-methyl-19-nor-17alpha-pregn -5(10)-en-20-yn-3-one |
| 05/25/2006 | US20060111331 Gave10 agonists for treating inflammation |
| 05/25/2006 | US20060111330 17,20(E)-dehydro vitamin D analogs and their uses |
| 05/25/2006 | US20060111329 Anticancer Agents Based on Regulation of Protein Prenylation |
| 05/25/2006 | US20060111328 matrix metalloproteinases (MMPs) inhibitor; N-(1-cyclohexylethyl)carbamoylphosphonic acid; anticarcinlgenic, coronary atherosclerosis, rheumatoid arthritis, tumor invasion, metastasis, angiogenesis, multiple sclerosis, periodontal disease, restenosis, heart failure, osteoporosis, liver cirrhosis |
| 05/25/2006 | US20060111327 Derivatives of triptolide having a high immunosuppressive effect and high water solubility, and uses thereof |
| 05/25/2006 | US20060111326 sulfonamidophosphonate-functional heteroaryl compounds that contain SO2-NH-P(O)(-OR)2 group; antiinflammatory and analgesics; e.g. N-[4-[4-chloro-5-(3-fluoro-4-methoxyphenyl)imidazol-1-yl]phenylsulfonyl]phosphoramidic acid; injectable COX-2 inhibitors |
| 05/25/2006 | US20060111325 Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use |
| 05/25/2006 | US20060111324 (+)-Ttrans-isomers of (1-phosphonomethoxy-2-alkylcyclopropyl)methyl nucleoside derivatives, process for the preparation of stereoisomers thereof, and use of antiviral agents thereof |
| 05/25/2006 | US20060111323 Use of polysiloxanes having quaternary ammonium groups as formulation auxiliaries, and compositions comprising them |
| 05/25/2006 | US20060111322 Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation |
| 05/25/2006 | US20060111321 And protected derivatives; arrests the proliferation of undifferentiated cells and induces their differentiation to monocytes; treating cancer, skin disorders, autoimmune disorders, inflammatory conditions, obesity and renal osteodystrophy |
| 05/25/2006 | US20060111319 Use of dextran sulfate |
| 05/25/2006 | US20060111318 Agent for treating eye diseases |
| 05/25/2006 | US20060111317 Synthesis of N-deacetylate N-sulfate derivatives of non-sulfated N-acetyl heparosan (HS) polysaccharides; rapid synthesis; high product yield; controlling coagulation and treating thrombosis |
| 05/25/2006 | US20060111316 Treatment of inflammatory, non-infectious, autoimmune, vasculitic, degenerative vascular, host-v-graft diseases, Alzheimers disease, and amyloidosis using mammalian, dsDNA vaccination |
| 05/25/2006 | US20060111311 caused by a flaviviridae family virus, such as hepatitis C virus; 4-amino-5-nitro-pyrrolo[2,3-d]pyrimidines |
| 05/25/2006 | US20060111310 from plants in sapindaceae family, such as Xanthoceras sorbifolia; ovarian, skin, bladder, prostate, leukocytes, and bone cancer cell growth inhiitor |
| 05/25/2006 | US20060111309 Chalcomycin derivatives |
| 05/25/2006 | US20060111308 Reducing central nervous system side effects of drugs such as antihypertensives, vasodilators, barbiturates, analgesics, cardiac stabilizers, glucocorticoids, and antibiotics, by coadministering with a blood-brain barrier transport protein modulator such as a flavonoid |
| 05/25/2006 | US20060111307 Methods and compositions for treating pain |
| 05/25/2006 | US20060111306 Administering folinic acid; anxiolytic agents; premenstrual syndrome; therapy for asthma; eating disorders |
| 05/25/2006 | US20060111305 Metabolites of certain [1,4]diazepino[6,7,1-ij]quinoline derivatives and methods of preparation and use thereof |
| 05/25/2006 | US20060111304 For therapy of pancreatitus, bilioecholic, gastroesophical relux (GERD), irritable bowel syndrome (IBS), non ulcerous dyspepsia |
| 05/25/2006 | US20060111303 N-[(1S)-3-{(2Z)-2-[(4R)-3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazino}-2,3-dioxo-1-(tetrahydro-2H-pyran-4-yl)propyl]cycloheptanecarboxamide; cysteine protease inhibitors; for the treatment of inflammatory, immune, ischemic, respiratory,circulatory, neuronal, blood, hepatic and metabolic diseases |
| 05/25/2006 | US20060111302 Compositions and methods to reduce mutagenesis |
| 05/25/2006 | US20060111288 Peripheral benzodiazepine receptor independent superoxide generation |
| 05/25/2006 | US20060111286 Method of modulating endothelial cell activity |
| 05/25/2006 | US20060111284 Method for treating cancer |
| 05/25/2006 | US20060111276 Enhanced oral bioavailability and increased uptake of the compound by gastrointestinal tract membrane transporter |
| 05/25/2006 | US20060111274 Methods and compositions for enhancing transport across biological membranes |
| 05/25/2006 | US20060111273 Water soluble paclitaxel derivatives |
| 05/25/2006 | US20060111272 such as psoriasis and inflammatory bowel disease, in a human or other host animals; 2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid |
| 05/25/2006 | US20060110520 Active oxygen eliminator derived from natural substance and use thereof |
| 05/25/2006 | US20060110476 Dietary foodstuff for positively influencing cardiovascular health |
| 05/25/2006 | US20060110474 Rubrofusarin glycoside-containing composition |
| 05/25/2006 | US20060110467 Cancer chemotherapy |
| 05/25/2006 | US20060110465 Compositions addressing inflammation and/or degenerative disorders |
| 05/25/2006 | US20060110463 Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillin |
| 05/25/2006 | US20060110462 Nanoparticulate compositions of tubulin inhibitor compounds |
| 05/25/2006 | US20060110459 Triple natural polymer viscoelastic composition |
| 05/25/2006 | US20060110458 Sustained release drug carrier |
| 05/25/2006 | US20060110457 Heat cured gel and method of making |
| 05/25/2006 | US20060110454 Extended release formulation of pramipexole dihydrochloride |
| 05/25/2006 | US20060110452 Dosage forms of risedronate |
| 05/25/2006 | US20060110451 Formulations of [1,4]diazepino[6,7,1-IJ]quinoline derivatives |
| 05/25/2006 | US20060110450 Bilayer tablet of telmisartan and amlodipine |
| 05/25/2006 | US20060110449 Pharmaceutical composition |
| 05/25/2006 | US20060110448 Combination of a macrolide and a local anesthetic for the treatment of dermatological diseases |
| 05/25/2006 | US20060110447 Controlled and continued delivery of rifaximin and/or other substances |
| 05/25/2006 | US20060110446 Deferacirox dispersible tablets |
| 05/25/2006 | US20060110445 Dispersible tablet for oral administration |
| 05/25/2006 | US20060110444 Gemfibrozil, fenofibrate, bezafibrate, clofibrate, ciprofibrate and active metabolites and analogues dissolved in a vehicle, which is hydrophobic, hydrophilic or water-miscible; improved bioavailability of the active ingredient upon oral administration |
| 05/25/2006 | US20060110443 toxic or potent core is incorporated into the dosage form via three-dimensional printing, as a solution, solubilization or suspension of solid particles in liquid, rather than by the more conventional handling and compressing of dry powder; allows greater bioavailability |
| 05/25/2006 | US20060110441 Lyophilized liposome formulations and method |
| 05/25/2006 | US20060110436 Phospholipid derivative |
| 05/25/2006 | US20060110434 drug such as risperidone, a melting point lowering agent such as acetic acid and sodium acetate, and an adhesive base; transdermal sustained release |
| 05/25/2006 | US20060110433 Adhesive patch |
| 05/25/2006 | US20060110427 Ophthalmic compositions comprising polyether substituted polymers |
| 05/25/2006 | US20060110425 Leech extracts for stents |
| 05/25/2006 | US20060110413 Novel Molecules dervied from noraporphine |
| 05/25/2006 | US20060110408 Immunological combination compositions and methods |
| 05/25/2006 | US20060110393 Novel proteins and use thereof |
| 05/25/2006 | US20060110391 Compositions and methods for the treatment of body weight disorders, including obesity |
| 05/25/2006 | US20060110387 Method for treating vasculitis |
| 05/25/2006 | US20060110385 Means and methods for diagnosing and treating affective disorders |
| 05/25/2006 | US20060110383 carcinoma; parenterally administering human anti-PD-1 antibody in which PD-L1 or PD-L2 is over-expressed postoperatively |
| 05/25/2006 | US20060110368 Medium for culturing autologous human progenitor stem cells and applications thereof |
| 05/25/2006 | US20060110358 Combination therapy for treatment of fibrotic disorders |
| 05/25/2006 | US20060110357 Bone putty composition that maintains granule suspension at reduced temperatures |
| 05/25/2006 | US20060110356 Ophthalmic drug delivery system using polymer micelle |
| 05/25/2006 | US20060110343 Cosmetic or dermopharmaceutical compositions comprising tyramine derivatives, method for preparing same, and use thereof |
| 05/25/2006 | US20060110333 Composition for nasal absorption |